Investors Sell Shares of Humana (HUM) on Strength (HUM)

Investors sold shares of Humana Inc (NYSE:HUM) on strength during trading on Thursday. $23.37 million flowed into the stock on the tick-up and $97.16 million flowed out of the stock on the tick-down, for a money net flow of $73.79 million out of the stock. Of all companies tracked, Humana had the 2nd highest net out-flow for the day. Humana traded up $1.26 for the day and closed at $249.01

Several analysts have recently commented on the stock. ValuEngine lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Cowen restated a “buy” rating and set a $285.00 target price on shares of Humana in a research report on Wednesday, December 13th. Cantor Fitzgerald restated a “hold” rating and set a $230.00 target price on shares of Humana in a research report on Tuesday, December 5th. Credit Suisse Group decreased their target price on shares of Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. Finally, BMO Capital Markets raised their target price on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a research report on Friday, November 10th. Twelve research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $256.30.

The stock has a market capitalization of $35,640.00, a price-to-earnings ratio of 19.61, a price-to-earnings-growth ratio of 1.68 and a beta of 0.88. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. The company had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. Humana’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the business earned $3.18 EPS. research analysts expect that Humana Inc will post 11.63 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.64%. Humana’s dividend payout ratio (DPR) is presently 12.60%.

Humana declared that its Board of Directors has authorized a share buyback plan on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

In other Humana news, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction on Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares in the company, valued at approximately $2,901,304.56. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the transaction, the senior vice president now owns 9,888 shares in the company, valued at approximately $2,432,151.36. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,115 shares of company stock worth $2,501,627. 0.80% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in HUM. Koch Industries Inc. purchased a new position in shares of Humana in the 2nd quarter valued at $404,000. Adviser Investments LLC purchased a new position in shares of Humana in the 3rd quarter valued at $635,000. Teachers Advisors LLC raised its stake in shares of Humana by 31.6% in the 2nd quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock valued at $151,792,000 after acquiring an additional 151,603 shares during the period. Prisma Capital Partners LP purchased a new position in shares of Humana in the 2nd quarter valued at $7,122,000. Finally, Wells Fargo & Company MN raised its stake in shares of Humana by 10.0% in the 3rd quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock valued at $402,799,000 after acquiring an additional 150,173 shares during the period. Institutional investors own 94.01% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Investors Sell Shares of Humana (HUM) on Strength (HUM)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2017/12/28/investors-sell-shares-of-humana-hum-on-strength-hum.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit